H, C., K, D. R., T, E., K, Z., W, D. M., AR, P. A., . . . K, B. (2025). Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model. Oncoimmunology, 14(1), 2540054. https://doi.org/10.1080/2162402X.2025.2540054
Chicago Style (17th ed.) CitationH, Ceuppens, et al. "Immune Modulation Following α and β- Radionuclide Therapy Targeting Fibroblast Activation Protein-α in a Preclinical Tumor Model." Oncoimmunology 14, no. 1 (2025): 2540054. https://doi.org/10.1080/2162402X.2025.2540054.
MLA (9th ed.) CitationH, Ceuppens, et al. "Immune Modulation Following α and β- Radionuclide Therapy Targeting Fibroblast Activation Protein-α in a Preclinical Tumor Model." Oncoimmunology, vol. 14, no. 1, 2025, p. 2540054, https://doi.org/10.1080/2162402X.2025.2540054.